Hong, Y., Ishizuka, T., Watanabe, A., Tachibana, M., Lee, M., Ishizuka, H., . . . Abutarif, M. (2021). Model‐based assessments of CYP3A‐mediated drug‐drug interaction risk of milademetan. Wiley.
Cita Chicago Style (17a ed.)Hong, Ying, Tomoko Ishizuka, Akiko Watanabe, Masaya Tachibana, Mark Lee, Hitoshi Ishizuka, Frank LaCreta, y Malaz Abutarif. Model‐based Assessments of CYP3A‐mediated Drug‐drug Interaction Risk of Milademetan. Wiley, 2021.
Cita MLA (8a ed.)Hong, Ying, et al. Model‐based Assessments of CYP3A‐mediated Drug‐drug Interaction Risk of Milademetan. Wiley, 2021.
Precaución: Estas citas no son 100% exactas.